Uremic tumoral calcinosis in hemodialysis patients: Clinicopatholological findings and identification of calcific deposits

被引:0
|
作者
Hamada, J [1 ]
Tamai, K [1 ]
Ono, W [1 ]
Saotome, K [1 ]
机构
[1] Kuwano Kyoritsu Hosp, Fukushima 9638034, Japan
关键词
uremic tumoral calcinosis; hemodialysis; calcium phosphate; carbonate apatite;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Extraskeletal calcifications generally develop in uremic patients. Periarticular massive calcifications, referred to as uremic tumoral calcinosis (UTC), represent solitary or multifocal calcium phosphate deposits. Our objectives were to clinically analyze a series of 8 patients with UTC undergoing hemodialysis, and to characterize calcium deposits in UTC. Methods. The clinical, radiological, and pathological features of 8 consecutive patients (4 men and 4 women, mean age 49 yrs) with UTC were analyzed, and treatment and outcome were evaluated. Calcitic specimens from the 8 patients were analyzed by x-ray diffraction, Raman spectroscopy, and infrared spectroscopy. Results. Unifocal UTC was observed in 5 patients, whereas multifocal lesions occurred in 3 patients. The most common sites of UTC were the shoulders, elbows, and hands. Elevated serum calcium and phosphorus and intact parathyroid hormone were detected in 63% (n = 5), 100% (n = 8), and 63% (n = 5) of the patients, respectively. An increased calcium-phosphorus (CaxP) product was observed in 6 patients. Medical intervention to decrease the CaxP product achieved complete remission in 3 of 5 patients with solitary UTC, whereas this treatment was ineffective for multiple UTC. The 8 calcium deposits were identified as carbonate apatite. Conclusion. The most important pathogenic factors in UTC are an increased CaxP product and hyperphosphoremia, which is not necessarily related to hyperparathyroidism. Medical intervention is effective for solitary UTC, but combined treatment (surgery and medical therapy) is required for multiple UTC. Calcium deposits in UTC are composed of carbonate apatite.
引用
收藏
页码:119 / 126
页数:8
相关论文
共 38 条
  • [21] MORE ABOUT TUMORAL CALCINOSIS IN MAINTENANCE HEMODIALYSIS-PATIENTS
    SCUTERI, RM
    OTERO, AB
    CHITCHOTY, E
    SRABSTEIN, H
    CAVCALLI, N
    BLANCO, OL
    MAN, Z
    GOTLIEB, D
    NEPHRON, 1993, 65 (02): : 334 - 335
  • [22] Tumoral calcinosis in uremic patients: a reply to Dietl et al.
    Ionova, D
    Zlatarska, S
    CLINICAL NEPHROLOGY, 2000, 53 (06) : 489 - 489
  • [23] UREMIC TUMORAL CALCINOSIS IN PATIENTS ON PERITONEAL DIALYSIS: CLINICAL, RADIOLOGIC, AND LABORATORY FEATURES
    Chu, Hung-Yi
    Chu, Pauling
    Lin, Yuh-Feng
    Chou, Heng-Kuang
    Lin, Shih-Hua
    PERITONEAL DIALYSIS INTERNATIONAL, 2011, 31 (04): : 430 - 439
  • [24] TUMORAL CALCINOSIS IN HEMODIALYSIS-PATIENTS (HD PTS) - ROLE OF ALUMINUM
    ZINS, B
    PETITCLERC, T
    BASILE, C
    URENA, P
    BARDIN, T
    ZINGRAFF, J
    DRUEKE, T
    KIDNEY INTERNATIONAL, 1989, 35 (01) : 267 - 267
  • [25] SUCCESSFUL TREATMENT OF MASSIVE UREMIC TUMORAL CALCINOSIS WITH DAILY HEMODIALYSIS AND VERY-LOW CALCIUM DIALYSATE
    FERNANDEZ, E
    MONTOLIU, J
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1994, 9 (08) : 1207 - 1209
  • [26] Different outcomes following parathyroidectomy in patients with uremic tumoral calcinosis: two case reports
    Jialin Li
    Xuan Li
    Xiuhong Dong
    Lin Ma
    Zhentao Guo
    Xuexun Chen
    BMC Nephrology, 24
  • [27] Different outcomes following parathyroidectomy in patients with uremic tumoral calcinosis: two case reports
    Li, Jialin
    Li, Xuan
    Dong, Xiuhong
    Ma, Lin
    Guo, Zhentao
    Chen, Xuexun
    BMC NEPHROLOGY, 2023, 24 (01)
  • [28] Tumoral calcinosis: Diffuse multifocal form in hemodialysis patients. Two case reports
    Ibrahim Montasser, D.
    Issouani, J.
    Hassani, M.
    Kabbaj, D.
    ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH, 2017, 103 (05) : 815 - 820
  • [29] BIOMONITORING OF EXPOSURE TO GENOTOXIC AGENTS AND TUMORAL MARKERS IN UREMIC PATIENTS UNDERGOING HEMODIALYSIS
    BERNAL, ML
    ANSON, JL
    SINUES, B
    SAENZ, MA
    LANUZA, J
    BARTOLOME, M
    MUTATION RESEARCH, 1993, 291 (03): : 291 - 291
  • [30] The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial
    Floege, Juergen
    Kubo, Yumi
    Floege, Anna
    Chertow, Glenn M.
    Parfrey, Patrick S.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 10 (05): : 800 - 807